APA (7th ed.) Citation

Kumar, S., Chakraborty, R., Roy, C., Basu, S., Hajra, A. K., Sen, P., . . . Kundu, M. (2025). Discovery of 1‐(Cyclopropylmethyl)‐2‐(Dibenzo[b,d]Thiophen‐2‐yl)‐1H‐Benzo[d]Imidazole‐5‐Carboxylic Acid as Orally Bioavailable EP4 Receptor Antagonist. Chemical Biology & Drug Design, 105(6), 1. https://doi.org/10.1111/cbdd.70132

Chicago Style (17th ed.) Citation

Kumar, Sanjay, et al. "Discovery of 1‐(Cyclopropylmethyl)‐2‐(Dibenzo[b,d]Thiophen‐2‐yl)‐1H‐Benzo[d]Imidazole‐5‐Carboxylic Acid as Orally Bioavailable EP4 Receptor Antagonist." Chemical Biology & Drug Design 105, no. 6 (2025): 1. https://doi.org/10.1111/cbdd.70132.

MLA (9th ed.) Citation

Kumar, Sanjay, et al. "Discovery of 1‐(Cyclopropylmethyl)‐2‐(Dibenzo[b,d]Thiophen‐2‐yl)‐1H‐Benzo[d]Imidazole‐5‐Carboxylic Acid as Orally Bioavailable EP4 Receptor Antagonist." Chemical Biology & Drug Design, vol. 105, no. 6, 2025, p. 1, https://doi.org/10.1111/cbdd.70132.